In Silico Prediction of Aridanin as a Potential Anticancer and Antibacterial Agent

Chi Godloves Fru; Yunus Başar; Melvis Akwen Chongong; Semiha Yenigün; G. Aponglen Ayimele; İbrahim Demirtas

doi:10.18016/ksutarimdoga.vi.1623765

TR EN

Aridanin'in Potansiyel Bir Antikanser ve Antibakteriyel Ajan Olarak İn Siliko Tahmini

Öz

Tetrapleura tetraptera'dan izole edilen Aridanin, 3-O-[β-D-glucopyranosyl-(2’-acetamido)]-3β-olean-12-en-28-oik asit, özellikle dirençli kanserlere karşı antikanser ilacı olarak kullanım için iyi potansiyellere sahip olduğu bildirilmiştir. Aridanin/doksorubisin ve kanser kemoterapisinde yer alan 6 enzim ve antibakteriyel 3 enzimin bağlanma modlarını değerlendirmek için bir in siliko çalışması yürütülmüştür. Ayrıca, olası biyoaktiviteleri ve farmakokinetik özellikleri hakkında tahminler yapılmıştır. Aridanin/doksorubisin enzim etkileşimleri, antikanser aktivitesini açıklamak için moleküler yerleştirme ve moleküler dinamik simülasyonları kullanılarak belirlenmiştir. Molekülün biyoaktivite, farmakokinetik özellikleri ve biyoyararlanım puanlarının tahminleri PASS, SwissADME ve pKCSM kullanılarak hesaplanmıştır. Sonuçlar, standart ilacınkine benzer MolDock puanları ve nispeten daha yüksek bağlanma enerjileriyle önceki deneysel verileri doğrulamıştır. Buna göre, aridanin teorik olarak doksorubisinden daha iyi bir çalışılan enzim inhibitörüdür. En yüksek inhibisyon topoizomeraz II alfa, DNA metiltransferaz ve DD-peptidaz için sırasıyla -9,9, -9,2 ve -10,9 kcal/mol bağlanma enerjileri olarak kaydedildi. Bu, aridaninin antikanser özelliğinin daha çok DNA ile ilişkili proteinlere müdahale yoluyla olabileceğini düşündürmektedir. Ek olarak, ADMET/PASS aridaninin toksik olmadığını, 0,56'lık iyi bir biyoyararlanım puanına sahip olduğunu ve birkaç farklı biyoaktivite gösterebileceğini öngörmüştür. Sonuç olarak, aridanin klinik çalışmalar için dikkate alınması gereken dirençli kanserlere ve bakterilere karşı güçlü bir kemoterapötik ajandır.

Anahtar Kelimeler

In Silico Prediction of Aridanin as a Potential Anticancer and Antibacterial Agent

Abstract

Aridanin, 3-O-[β-D-glucopyranosyl-(2’-acetamido)]-3β-olean-12-en-28-oic acid, isolated from Tetrapleura tetraptera, is reported to have good potential for use as an anticancer drug, especially against resistant cancers. In an in-silico study, the binding modes of aridanin/doxorubicin and 6 enzymes involved in cancer chemotherapy, as well as 3 antibacterial enzymes, were investigated. Also, predictions on its possible bioactivities and pharmacokinetic properties were made. Aridanin/doxorubicin enzyme interactions were determined using molecular docking and molecular dynamics simulations to attempt an explanation for its anticancer activity. Predictions of bioactivity, pharmacokinetic properties, and bioavailability scores of the molecule were calculated using PASS, SwissADME, and pKCSM. The results corroborated previous experimental data, with MolDock scores comparable to those of the standard drug and relatively higher binding energies. Accordingly, aridanin theoretically is a better inhibitor of the studied enzymes than doxorubicin. The highest inhibition recorded binding energies of -9.9, -9.2, and -10.9 kcal/mol for topoisomerase II alpha, DNA methyltransferase, and DD-peptidase, respectively. This suggests that aridanin’s anticancer property may be more through interference with DNA-related proteins. In addition, ADMET/PASS anticipated that aridanin is not toxic, has a good bioavailability score of 0.56, and may display several different bioactivities. Consequently, aridanin is a potent chemotherapeutic agent against resistant cancers and bacteria that should be considered for clinical studies.

Keywords

Proje Numarası

3240328525

Teşekkür

We acknowledge support from TÜBİTAK through grant no: 3240328525. We are also thankful to Pr. Dr. Shaheen F. and the ICCBS where the spectra were recorded.

Kaynakça

Abdullahi, S. H., Adamu, U., Adamu, S. G., Sani, U., & and Umar, A. B. (2022). Molecular Docking , ADMET and Pharmacokinetic properties predictions of some di-aryl Pyridinamine derivatives as Estrogen Receptor (Er+) Kinase Inhibitors. Egyptian Journal of Basic and Applied Sciences, 9(1), 180-204. https://doi.org/10.1080/2314808X.2022.2050115
Aderibigbe, A., Iwalewa, E. O., Adesina, K. S., & Agboola, I. O. (2011). Anxiolytic effect of aridanin isolated from Tetrapleura tetraptera in mice. International Journal of Biological and Chemical Sciences, 4. https://doi.org/10.4314/ijbcs.v4i5.65523
Adesina, S., Iwalewa, E. O., & Johnny, I. (2016). Tetrapleura tetraptera Taub- Ethnopharmacology, Chemistry, Medicinal and Nutritional Values- A Review. British Journal of Pharmaceutical Research, 12, 1-22. https://doi.org/10.9734/BJPR/2016/26554
Adesina, S. K., & Reisch, J. (1985). A triterpenoid glycoside from Tetrapleura tetraptera fruit. Phytochemistry, 24(12), 3003-3006. https://doi.org/https://doi.org/10.1016/0031-9422(85)80044-3
Alminderej, F., Bakari, S., Almundarij, T. I., Snoussi, M., Aouadi, K., & Kadri, A. (2020). Antioxidant Activities of a New Chemotype of Piper cubeba L. Fruit Essential Oil (Methyleugenol/Eugenol): In Silico Molecular Docking and ADMET Studies. Plants (Basel), 9(11). https://doi.org/10.3390/plants9111534
Altshuler, R. D., Minasian, L. M., Schweppe, C. A., & Kadan-Lottick, N. S. (2025). Chemotherapy-induced peripheral neuropathy research: a National Institutes of Health (NIH) grant portfolio analysis (2014-2023). JNCI Cancer Spectrum, 9(3). https://doi.org/10.1093/jncics/pkaf039
Anyamele, T., Onwuegbuchu, P. N., Ugbogu, E. A., & Ibe, C. (2023). Phytochemical composition, bioactive properties, and toxicological profile of Tetrapleura tetraptera. Bioorganic Chemistry, 131, 106288. https://doi.org/10.1016/j.bioorg.2022.106288
Bandyopadhyay, D., Lopez, G., Cantu, S., Balboa, S., Garcia, A., Silva, C., & Valdes, D. (2018). Key Enzymes in Cancer: Mechanism of Action and Inhibition With Anticancer Agents.

Başar, Y., Hosaflıoğlu, İ., & Erenler, R. (2024). Phytochemical analysis of Robinia pseudoacacia flowers and leaf: quantitative analysis of natural compounds and molecular docking application. Turkish Journal of Biodiversity, 7(1), 1-10.
Başar, Y., & Karadağ, M. (2024). Phytochemical Content Analysis of Different Lavandula Officinalis Extracts by LC-ESI-MS/MS and In Silico Molecular Docking Studies. Turkish Journal of Applied Sciences and Technology, 5(1), 12-22. https://doi.org/10.5281/zenodo.11237944
Başar, Y., Yenigün, S., Alma, M. H., Demirtas, İ., & Ozen, T. (2025). Fruit extracts of Rosa canina L. and Rosa pimpinellifolia L.: Phytochemical profiles, in vitro antioxidant, anti-inflammatory, xanthine oxidase inhibitory effects, and in silico molecular dynamics studies. Kahramanmaraş Sütçü İmam Üniversitesi Tarım ve Doğa Dergisi, 28(3), 636-649. https://doi.org/https://doi.org/10.18016/ksutarimdoga.vi.1639294
Bonsou, I. N., Mbaveng, A. T., Nguenang, G. S., Chi, G. F., Kuete, V., & Efferth, T. (2022). Cytotoxicity, acute and sub-chronic toxicities of the fruit extract of Tetrapleura tetraptera (Schumm. & Thonn.) Taub. (Fabaceae). BMC Complement Med Ther, 22(1), 178. https://doi.org/10.1186/s12906-022-03659-1
Brogi, S., Ramalho, T. C., Kuca, K., Medina-Franco, J. L., & Valko, M. (2020). Editorial: In silico Methods for Drug Design and Discovery. Front Chem, 8, 612. https://doi.org/10.3389/fchem.2020.00612
Bruno, S., Bersani, M., Astore, S., Chiabotto, G., Barge, A., Binello, A., & Spyrakis, F. (2022). Lack of interaction of the fluorosurfactant C6O4 with human renal transporters: In vitro/in silico analysis. Toxicology, 476, 153257. https://doi.org/10.1016/j.tox.2022.153257
Chen, C., Lu, L., Yan, S., Yi, H., Yao, H., Wu, D., He, G., Tao, X., & Deng, X. (2018). Autophagy and doxorubicin resistance in cancer. Anti-Cancer Drugs, 29(1), 1-9. https://doi.org/10.1097/cad.0000000000000572
Chhikara, B., & Parang, K. (2022). Global Cancer Statistics 2022: The Trends Projection Analysis. Chemical Biology Letters, 10, 451.
Chi, G. F., Khan, S., Başar, Y., Kuete, J. R. N., Matieta, V. Y., Kuete, J. B. T., Megaptche, J. F., Chongong, M. A., Yenigün, S., Ayimele, G. A., Mbaveng, A. T., Kuete, V., & Shaheen, F. (2025). Antibacterial flavonoids from Tetrapleura tetraptera (Fabaceae) fruit pulp, in silico studies. South African Journal of Botany, 180, 96-106. https://doi.org/https://doi.org/10.1016/j.sajb.2025.02.026
Chi, G. F., Serab, K., N., K. J. R., Y., M. V., O., O. J., N., T. A., F., M. J., A., C. M., B., D. T., Victor, K., & and Shaheen, F. (2024). Triterpenoid saponins from the fruit pulp of Tetrapleura tetraptera (Fabaceae). Natural Product Research, 1-13. https://doi.org/10.1080/14786419.2024.2426072
Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7, 42717. https://doi.org/10.1038/srep42717
Darboe, S., Bradbury, R. S., Phelan, J., Kanteh, A., Muhammad, A.-K., Worwui, A., Yang, S., Nwakanma, D., Perez-Sepulveda, B., & Kariuki, S. (2022). Genomic diversity and antimicrobial resistance among non-typhoidal Salmonella associated with human disease in The Gambia. Microbial Genomics, 8(3), 000785. https://doi.org/https://doi.org/10.1099/mgen.0.000785
Decherchi, S., & Cavalli, A. (2020). Thermodynamics and Kinetics of Drug-Target Binding by Molecular Simulation. Chem Rev, 120(23), 12788-12833. https://doi.org/10.1021/acs.chemrev.0c00534
Elkaeed, E. B., Yousef, R. G., Elkady, H., Gobaara, I. M. M., Alsfouk, B. A., Husein, D. Z., Ibrahim, I. M., Metwaly, A. M., & Eissa, I. H. (2022). Design, Synthesis, Docking, DFT, MD Simulation Studies of a New Nicotinamide-Based Derivative: In Vitro Anticancer and VEGFR-2 Inhibitory Effects. Molecules, 27(14), 4606. https://www.mdpi.com/1420-3049/27/14/4606
Espinosa, E., Zamora, P., Feliu, J., & González Barón, M. (2003). Classification of anticancer drugs--a new system based on therapeutic targets. Cancer Treatment Reviews, 29(6), 515-523. https://doi.org/10.1016/s0305-7372(03)00116-6
Fulda, S. (2008). Betulinic Acid for Cancer Treatment and Prevention. International Journal of Molecular Sciences, 9(6), 1096-1107. https://www.mdpi.com/1422-0067/9/6/1096
Gok, M., Basar, Y., Yenigun, S., Ipek, Y., Behcet, L., Ozen, T., & Demirtas, I. (2025). Bioactive Apigenin‐7‐O‐β‐Glucoside and Rosmarinic Acid Molecules From Two Nepeta Species: Bioactivity‐Guided Isolation, In Vitro Evaluations, Pharmacokinetic and In Silico Approaches as Metabolic Enzyme Inhibition Agents. Phytochemical Analysis. https://doi.org/https://doi.org/10.1002/pca.3536
Gupta, N. (2022). A review on recent developments in the anticancer potential of oleanolic acid and its analogs (2017-2020). Mini Reviews in Medicinal Chemistry, 22(4), 600-616. https://doi.org/10.2174/1389557521666210810153627
Hafezi, S., & Rahmani, M. (2021). Targeting BCL-2 in Cancer: Advances, Challenges, and Perspectives. Cancers, 13(6). https://doi.org/10.3390/cancers13061292
Horchani, M., Heise, N. V., Csuk, R., Ben Jannet, H., Harrath, A. H., & Romdhane, A. (2022). Synthesis and In Silico Docking Study towards M-Pro of Novel Heterocyclic Compounds Derived from Pyrazolopyrimidinone as Putative SARS-CoV-2 Inhibitors. Molecules, 27(16). https://doi.org/10.3390/molecules27165303
İpek, Y., Yunus, B., Semiha, Y., Lütfi, B., Tevfik, Ö., & and Demirtaş, İ. In vitro bioactivities and in silico enzyme interactions of abietatrien-3β-ol by bio-guided isolation from Nepeta italica subsp. italica. Journal of Biomolecular Structure and Dynamics, 1-24. https://doi.org/10.1080/07391102.2024.2322626
Kamdem Kengne, M. H., Gertrude Laura, F., Silihe, K., More, G., Mphahlele, M., Moswetsa, T., Tata, C., Tonga, J., Ojo, O., Thierry, F., Mmutlane, E., & Ndinteh, D. (2022). Cytotoxic and antibacterial activities of compounds isolated from the fruits and stem-bark of Tetrapleura tetraptera (Schumach. & Thonn.) Taub. (Fabaceae). Medicinal Chemistry Research, 31. https://doi.org/10.1007/s00044-022-02956-1
Kaur, J., Singh, H., & Sethi, T. (2024). Emerging trends in antimicrobial resistance in bloodstream infections: multicentric longitudinal study in India (2017–2022). The Lancet Regional Health - Southeast Asia, 26. https://doi.org/10.1016/j.lansea.2024.100412
Kim, D. W., & Cha, C. J. (2021). Antibiotic resistome from the One-Health perspective: understanding and controlling antimicrobial resistance transmission. Exp Mol Med, 53(3), 301-309. https://doi.org/10.1038/s12276-021-00569-z
Kohanski, M. A., Dwyer, D. J., & Collins, J. J. (2010). How antibiotics kill bacteria: from targets to networks. Nature Reviews: Microbiology, 8(6), 423-435. https://doi.org/10.1038/nrmicro2333
Kumar, S., Ahmad, M., Waseem, M., & Pandey, A. K. (2015). Drug Targets for Cancer Treatment: An Overview. Medicinal Chemistry, 5. https://doi.org/10.4172/2161-0444.1000252
Kumari, R., Kumar, R., Consortium, O. S. D. D., & Lynn, A. (2014). g_mmpbsa A GROMACS tool for high-throughput MM-PBSA calculations. Journal of chemical information and modeling, 54(7), 1951-1962.
Lagunin, A., Stepanchikova, A., Filimonov, D., & Poroikov, V. (2000). PASS: prediction of activity spectra for biologically active substances. Bioinformatics, 16(8), 747-748. https://doi.org/10.1093/bioinformatics/16.8.747
Lao, J., Madani, J., Puértolas, T., Alvarez, M., Hernández, A., Pazo-Cid, R., Artal, A., & Antón Torres, A. (2013). Liposomal Doxorubicin in the treatment of breast cancer patients: a review. J Drug Deliv, 2013, 456409. https://doi.org/10.1155/2013/456409
Lin, J. H. (2016). Review structure- and dynamics-based computational design of anticancer drugs. Biopolymers, 105(1), 2-9. https://doi.org/10.1002/bip.22744
Liu, X., Shi, D., Zhou, S., Liu, H., Liu, H., & Yao, X. (2018). Molecular dynamics simulations and novel drug discovery. Expert Opin Drug Discov, 13(1), 23-37. https://doi.org/10.1080/17460441.2018.1403419
Majewski, M., Ruiz Carmona, S., & Barril, X. (2019). An investigation of structural stability in protein-ligand complexes reveals the balance between order and disorder. Communications Chemistry, 2, 1-8. https://doi.org/10.1038/s42004-019-0205-5
Marvalim, C., Datta, A., & Lee, S. C. (2023). Role of p53 in breast cancer progression: An insight into p53 targeted therapy. Theranostics, 13(4), 1421-1442. https://doi.org/10.7150/thno.81847
Mbaveng, A. T., Chi, G. F., Bonsou, I. N., Abdelfatah, S., Tamfu, A. N., Yeboah, E. M. O., Kuete, V., & Efferth, T. (2020). N-acetylglycoside of oleanolic acid (aridanin) displays promising cytotoxicity towards human and animal cancer cells, inducing apoptotic, ferroptotic and necroptotic cell death. Phytomedicine, 76, 153261. https://doi.org/10.1016/j.phymed.2020.153261
Mbaveng, A. T., Chi, G. F., Bonsou, I. N., Ombito, J. O., Yeboah, S. O., Kuete, V., & Efferth, T. (2021). Cytotoxic phytochemicals from the crude extract of Tetrapleura tetraptera fruits towards multi-factorial drug resistant cancer cells. J Ethnopharmacol, 267, 113632. https://doi.org/10.1016/j.jep.2020.113632
Meredith, A. M., & Dass, C. R. (2016). Increasing role of the cancer chemotherapeutic doxorubicin in cellular metabolism. Journal of Pharmacy and Pharmacology, 68(6), 729-741. https://doi.org/10.1111/jphp.12539
Micallef, I., & Baron, B. (2020). Doxorubicin: An Overview of the Anti-Cancer and Chemoresistance Mechanisms OPEN ACCESS. 3, 1031.
Namba-Nzanguim, C. T., Simoben, C. V., Bekono, B. D., Tietjen, I., Cassel, J., Salvino, J. M., Montaner, L. J., Davis, R. A., & Ntie-Kang, F. (2024). Investigation of some plant stilbenoids and their fragments for the identification of inhibitors of SARS-CoV-2 viral spike/ACE2 protein binding. The Microbe, 3, 100059. https://doi.org/https://doi.org/10.1016/j.microb.2024.100059
Okeke, I. N., de Kraker, M. E. A., Van Boeckel, T. P., Kumar, C. K., Schmitt, H., Gales, A. C., Bertagnolio, S., Sharland, M., & Laxminarayan, R. (2024). The scope of the antimicrobial resistance challenge. The Lancet, 403(10442), 2426-2438. https://doi.org/10.1016/S0140-6736(24)00876-6
Ooi, K. X., Poo, C. L., Subramaniam, M., Cordell, G. A., & Lim, Y. M. (2023). Maslinic acid exerts anticancer effects by targeting cancer hallmarks. Phytomedicine, 110, 154631. https://doi.org/10.1016/j.phymed.2022.154631
Qian, S., Wei, Z., Yang, W., Huang, J., Yang, Y., & Wang, J. (2022). The role of BCL-2 family proteins in regulating apoptosis and cancer therapy. Frontiers in Oncology, 12, 985363. https://doi.org/10.3389/fonc.2022.985363
Rapaport, D. (2004). The Art of Molecular Dynamics Simulaton. The Art of Molecular Dynamics Simulation. https://doi.org/10.1017/CBO9780511816581
Rehman, M. T., AlAjmi, M. F., Hussain, A., Rather, G. M., & Khan, M. A. (2019). High-Throughput Virtual Screening, Molecular Dynamics Simulation, and Enzyme Kinetics Identified ZINC84525623 as a Potential Inhibitor of NDM-1. International Journal of Molecular Sciences, 20(4). https://doi.org/10.3390/ijms20040819
Siegel, R. L., Miller, K. D., Wagle, N. S., & Jemal, A. (2023). Cancer statistics, 2023. CA: A Cancer Journal for Clinicians, 73(1), 17-48. https://doi.org/10.3322/caac.21763
Sikam, K., Ntabo, V., Happi, G., Meikeu, L., & Wansi, J. (2022). Chemistry and pharmacological aspects of Aridanin, a lead compound from Tetrapleura tetraptera (Fabaceae). Natural Resources for Human Health, 3. https://doi.org/10.53365/nrfhh/152273
Sikam, K. G., Happi, G. M., Ahmed, S. A., Wakeu, B. N. K., Meikeu, L. Z., Salau, S., & Wansi, J. D. (2022). In vitro antiplasmodial, molecular docking and pharmacokinetics studies of specialized metabolites from Tetrapleura tetraptera (Fabaceae). South African Journal of Botany, 151, 949-959. https://doi.org/https://doi.org/10.1016/j.sajb.2022.11.021
Spencer, A. C., & Panda, S. S. (2023). DNA Gyrase as a Target for Quinolones. Biomedicines, 11(2)., 1-15. https://doi.org/10.3390/biomedicines11020371
Taiwo, B. J., Olubiyi, O. O., Wang, X., Fisusi, F. A., Akinniyi, G. A., Van Heerden, F. R., & Strodel, B. (2018). Schistosomiasis: Snail-vector control, molecular modelling and dynamic studies of bioactive N-acetylglycoside saponins from Tetrapleura tetraptera. Comput Biol Chem, 77, 363-372. https://doi.org/10.1016/j.compbiolchem.2018.09.011
Tang, Z.-Y., Li, Y., Tang, Y.-T., Ma, X.-D., & Tang, Z.-Y. (2022). Anticancer activity of oleanolic acid and its derivatives: Recent advances in evidence, target profiling and mechanisms of action. Biomedicine and Pharmacotherapy, 145, 112397. https://doi.org/https://doi.org/10.1016/j.biopha.2021.112397
Velazquez-Meza, M. E., Galarde-López, M., Carrillo-Quiróz, B., & Alpuche-Aranda, C. M. (2022). Antimicrobial resistance: One Health approach. Vet World, 15(3), 743-749. https://doi.org/10.14202/vetworld.2022.743-749
Wang, W., Albadari, N., Du, Y., Fowler, J. F., Sang, H. T., Xian, W., McKeon, F., Li, W., Zhou, J., & Zhang, R. (2024). MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future. Pharmacological Reviews, 76(3), 414-453. https://doi.org/10.1124/pharmrev.123.001026
WHO. (2024). WHO bacterial priority pathogens list, 2024: bacterial pathogens of public health importance, to guide research, development, and strategies to prevent and control antimicrobial resistance. World Health Organization.
Wojciechowski, M., Milewski, S., Mazerski, J., & Borowski, E. (2005). Glucosamine-6-phosphate synthase, a novel target for antifungal agents. Molecular modelling studies in drug design. Acta Biochimica Polonica, 52(3), 647-653.
Ye, F., Ma, P., Zhang, Y. Y., Li, P., Yang, F., & Fu, Y. (2018). Herbicidal Activity and Molecular Docking Study of Novel ACCase Inhibitors. Frontiers of Plant Science, 9, 1850. https://doi.org/10.3389/fpls.2018.01850
Yenigun, S., Yunus, B., Yasar, I., Lutfi, B., Ibrahim, D., & and Ozen, T. (2024a). Comprehensive evaluation of Ixoroside: An iridoid glycoside from Nepeta aristata and N. baytopii, assessing antioxidant, antimicrobial, enzyme inhibitory, DNA protective properties, with computational and pharmacokinetic analyses. Journal of Biologically Active Products from Nature, 14(3), 286-315. https://doi.org/10.1080/22311866.2024.2358785
Yenigun, S., Yunus, B., Yasar, I., Lutfi, B., Ibrahim, D., & and Ozen, T. (2024b). DNA protection, molecular docking, molecular dynamic, enzyme inhibition, and kinetics studies of apigenin isolated from Nepeta baytopii Hedge & Lamond by bioactivity-guided fractionation. Journal of Biomolecular Structure and Dynamics, 1-12. https://doi.org/10.1080/07391102.2024.2442753
Yenigün, S., Başar, Y., Yılmaz, S., Demirtas, İ., & Ozen, T. (2024c). Phytochemical Contents and Antioxidant Activity Paliurus Spina-Christi Miller Leaf and Seed Extracts: PASS Predictions, In Silico Studies on Xanthine Oxidase and Cytochrome P450 1A1. Current Perspectives on Medicinal and Aromatic Plants, 7(2), 96-106. https://doi.org/10.38093/cupmap.1516991
Yoshino, T., Shiina, H., Urakami, S., Kikuno, N., Yoneda, T., Shigeno, K., & Igawa, M. (2006). Bcl-2 expression as a predictive marker of hormone-refractory prostate cancer treated with taxane-based chemotherapy. Clin Cancer Res, 12(20 Pt 1), 6116-6124. https://doi.org/10.1158/1078-0432.Ccr-06-0147
Yousef, R. G., Albaraa, I., M., K. M., M., E. W., M., G. I. M., M., M. A. B., B., E. E., A., A. A., M., M. A., & and Eissa, I. H. (2022). Discovery of new nicotinamides as apoptotic VEGFR-2 inhibitors: virtual screening, synthesis, anti-proliferative, immunomodulatory, ADMET, toxicity, and molecular dynamic simulation studies. Journal of Enzyme Inhibition and Medicinal Chemistry, 37(1), 1389-1403. https://doi.org/10.1080/14756366.2022.2070744
Zhang, C., Wang, X., Du, J., Gu, Z., & Zhao, Y. (2021). Reactive Oxygen Species-Regulating Strategies Based on Nanomaterials for Disease Treatment. Adv Sci (Weinh), 8(3), 2002797. https://doi.org/10.1002/advs.202002797
Zhang, Z., Wang, G., Li, Y., Lei, D., Xiang, J., Ouyang, L., Wang, Y., & Yang, J. (2022). Recent progress in DNA methyltransferase inhibitors as anticancer agents. Frontiers in Pharmacology, 13, 1072651. https://doi.org/10.3389/fphar.2022.1072651
Zhao, Y., Yu, H., & Hu, W. (2014). The regulation of MDM2 oncogene and its impact on human cancers. Acta Biochim Biophys Sin (Shanghai), 46(3), 180-189. https://doi.org/10.1093/abbs/gmt147
Zheng, K., Dong, Y., Yang, R., Liang, Y., Wu, H., & He, Z. (2021). Regulation of ferroptosis by bioactive phytochemicals: Implications for medical nutritional therapy. Pharmacological Research, 168, 105580. https://doi.org/10.1016/j.phrs.2021.105580
Znati, M., Bordes, C., Forquet, V., Lantéri, P., Ben Jannet, H., & Bouajila, J. (2019). Synthesis, molecular properties, anti-inflammatory and anticancer activities of novel 3-hydroxyflavone derivatives. Bioorganic Chemistry, 89, 103009. https://doi.org/10.1016/j.bioorg.2019.103009

Ayrıntılar

Birincil Dil

İngilizce

Konular

Bitki Biyokimyası , Eczacılık ve İlaç Bilimleri (Diğer)

Bölüm

Araştırma Makalesi

Yazarlar

Chi Godloves Fru ^*
0000-0002-1484-3995
Türkiye

Yunus Başar
0000-0002-7785-3242
Türkiye

Melvis Akwen Chongong
0009-0002-3641-040X
Cameroon

Semiha Yenigün
0000-0002-1979-5427
Türkiye

G. Aponglen Ayimele
0000-0002-1070-1236
Cameroon

İbrahim Demirtas
0000-0001-8946-647X
Türkiye

Erken Görünüm Tarihi

21 Ocak 2026

Yayımlanma Tarihi

21 Ocak 2026

Gönderilme Tarihi

24 Ocak 2025

Kabul Tarihi

16 Haziran 2025

Yayımlandığı Sayı

Yıl 2026 Cilt: 29 Sayı: 2

DOI

https://doi.org/10.18016/ksutarimdoga.vi.1623765

IZ

https://izlik.org/JA95BW98JH

Kaynak Göster

RIS / Bibtex

APA

Godloves Fru, C., Başar, Y., Chongong, M. A., Yenigün, S., Ayimele, G. A., & Demirtas, İ. (2026). In Silico Prediction of Aridanin as a Potential Anticancer and Antibacterial Agent. Kahramanmaraş Sütçü İmam Üniversitesi Tarım ve Doğa Dergisi, 29(2), 265-284. https://doi.org/10.18016/ksutarimdoga.vi.1623765

Aridanin'in Potansiyel Bir Antikanser ve Antibakteriyel Ajan Olarak İn Siliko Tahmini

Öz

Anahtar Kelimeler

In Silico Prediction of Aridanin as a Potential Anticancer and Antibacterial Agent

Abstract

Keywords

Proje Numarası

Teşekkür

Kaynakça

Ayrıntılar

Birincil Dil

Konular

Bölüm

Yazarlar

Erken Görünüm Tarihi

Yayımlanma Tarihi

Gönderilme Tarihi

Kabul Tarihi

Yayımlandığı Sayı

DOI

IZ

Kaynak Göster

e-ISSN: 2619-9149